An indirect enzyme-linked immunosorbent assay system for determination of antibody levels to the group A streptococcal cell wall carbohydrate antigen is described. Optimal conditions for antigen preparation, purification, and conjugation to poly-L-lysine for adequate adsorption to the solid phase are presented. After the description of the antistreptolysin 0 test, several methods for measuring antibody responses to other group A streptococcal antigens were introduced. These included the antiDNase and the anti-NADase tests (3, 24), designed to measure antibody to streptococcal extracellular products. Subsequently, Halpern and Goldstein (10) described a radioimmunoassay for antibody to a cell wall antigen, the streptococcal group-specific carbohydrate. This test has been used to measure antibody to the group A carbohydrate (ACHO) in the serum of patients with group A streptococcal infections and their complications, e.g., nephritis or rheumatic fever (7).
itin technique requiring the use of radiolabeled, purified streptococcal cell wall polysaccharide. The need to use substantial amounts of radioactive precursors, the requirement for extensive processing to prepare small amounts of labeled antigen, and the potential for aberrant results resulting from the presence of contaminants in the antigen preparation limit the availability and the generalized usefulness of the technique. The present study was therefore undertaken to determine whether the enzyme-linked immunosorbent assay (ELISA) could offer a more practical alternative to the radioimmunoassay technique.
MATERIALS AND METHODS
Group A streptococcal carbohydrate antigen. For most experiments the antigen consisted of formamideextracted, group-specific ACHO prepared as follows. Group A streptococci were grown in Todd-Hewitt broth overnight, and the cells were collected and washed. Cell walls were prepared by Mickle disintegration and differential centrifugation by the method of Salton and Home (20) . Carbohydrate was extracted from lyophilized cell walls by the hot formamide method of Fuller as modified by Heymann et al. (11) and assayed for the rhamnose and glucosamine content as previously described (6, 19) . For selected experiments, the ACHO antigen was alternatively prepared by acid extraction or phage lysis of group A streptococci as previously described (13, 14) or by extraction with the Streptomyces albus enzyme (16) , Antigen conjugation to PLL. ACHO, like other bacterial polysaccharides, adsorbs poorly to plastic surfaces such as the tubes or microtiter plates used in ELISA assays, due to the net negative charge conferred by acidic groups on the antigen. To overcome this problem we conjugated ACHO to poly-L-lysine (PLL), which then adsorbs to plastic supporting materials, by the method of Gray (9) . Briefly, 2 mg of formamideextracted ACHO (in 0.2 ml of distilled water) was added to 1.0 ml of 0.01 N NaOH (pH 12.0) and mixed gently for 10 s. This solution was then transferred to a tube containing approximately 5 .0 mg of cyanuric chloride (Aldrich Chemical Co., Milwaukee, Wis.) and mixed gently with continuous monitoring of the pH of the solution. When the pH had fallen to 8.3 to 8.4, the supernatant was quickly transferred to a tube containing 0.2 ml of PLL (molecular weight 40,000; Sigma Chemical Co., St. Louis, Mo.), 1.0 mg/ml in 0.05 M Tris buffer (pH 8.1), avoiding transfer of any of the cyanuric chloride crystals. The final pH after this step was between 8.0 to 8.2. The solution was dialyzed at 4°C for 18 h against phosphate-buffered saline (PBS; pH 7.4). The ACHO-PLL conjugate may be stored at 4°C for up to 6 months without significant loss of activity.
Buffers. PBS (pH 7.4) was found superior to bicarbonate buffer (pH 9.6) as a coating buffer for preparation of antigen-coated plates. Washing buffer consisted of PBS (pH 7.4) containing 0.05% (vol/vol) polysorbate (Tween 20; Sigma), and 0.5 M NaCi (PBS-TNaCl). Preliminary experiments demonstrated that the PBS-T-NaCl buffer was superior to PBS alone, PBS with 0.05% Tween 20, or PBS with 0.5% Tween 20 and 0.5 M NaCl in inhibiting the nonspecific adherence of nonimmune human sera to the antigen-coated plate.
Preparation pool serum to the wells of an ACHO antigen-coated plate. Serial twofold dilution of the sera was achieved by adding the initial serum dilutions to the top wells in the plate, dispensing equal amounts (0.05 ml) of the PBS-T-NaCl buffer to the wells in the lower rows, and making serial dilutions with a multichanneled pipette (Titertek; Flow Laboratories, Inc., Rockville, Md.). Sera were incubated in the plates for 2 h at 37°C. The plate was then washed three times in distilled water and once in PBS-T-NaCl as described above. Next, 0.05 ml of an appropriate dilution of alkaline phosphatase-conjugated sheep anti-human immunoglobulin in PBS-T-NaCl was added to the wells and incubated for 2 h at 37°C. The plate was then washed as above, 0.1 ml of p-nitrophenylphosphate substrate (1.0 mg/ml) was added to each well, and plates were incubated at 37°C for 30 min. Absorbance of the substrate was measured at 405 nm in a multichanneled photometer (Titertek Multiskan; Flow Laboratories).
The absorbance of the test sera was compared with that of the serial dilutions of the reference pool serum which served as a constant internal control. A plot of optical density (OD) versus serum dilution was made for the reference pool and test sera on a semilog scale (Fig. 1) (Fig. 2) . Only minimal background binding occurred in the wells coated with PLL without ACHO antigen. The binding of the reference serum was compared to serum shown to contain no antibody by the radioimmunoassay. OD readings for the latter serum at dilutions of 1:100 and higher did not exceed background (Fig. 2) .
Antigen preparation: effect of ACHO concentrations. The concentration of the ACHO antigen needed to yield an optimal conjugate with the PLL was investigated. The rhamnose content of a formamide-extracted ACHO preparation was determined and found to be 65%. Samples (0.2 ml) of this preparation containing 1.0, 2.0, 3.0, and 6.0 mg of rhamnose per ml were conjugated with 0.2 ml of rLL (1 mg/ml) by the procedure described above. Microtiter plates coated with various dilutions (1:50 to 1:400) of the four ACHO-PLL preparations were used to assay the relative binding of the reference serum and two other sera. Binding of serum antibody increased with increasing rhamnose content of the ACHO-PLL preparations, reaching a plateau at 3.0 to 6.0 mg of rhamnose per ml (Table 1) . For subsequent conjugations of the ACHO to PLL, 0.2 ml of the formamide-extracted ACHO (at 10 mg/ml), equivalent to 6.0 mg of rhamnose per ml, was used.
Source of ACHO for antigen preparations. ACHO preparations extracted by different methods were tested for their efficacy in measuring (Fig. 3) . The correlation coefficient for corresponding titers in the 60 sera was r = 0.664, giving a T value of 6.77 and a P value of <0.0001.
Quantitation of ACHO-specific IgG antibody.
To examine the sensitivity of the ELISA and to express the results in absolute or gravimetric terms rather than relative titer values, we assayed affinity-purified ACHO antibody in parallel 4.0 with the reference standard pool serum by the ELISA technique. Bound IgG antibody was 3A titer and ra-detected by using an isotype-specific, alkaline -HO-Sixty sera phosphatase-conjugated anti-human IgG reagent vels to ACHO as in these experiments. The purified antibody to ity in the radio-ACHO gave linear absorbance readings between ISA system. A 20 and 300 ng of IgG per ml (1.05 to 15 ng of IgG ty with log anti-added per well) (Fig. 4) tients with rheumatic heart disease and has been utilized as a marker for persistent rheumatic mitral valvular disease (2, 7, 23) . Previous investigators have used radioimmune precipitation (7, 10) , double diffusion in gel (4, 25) , or the tanned erythrocyte hemagglutination techniques (8, 12, 17, 21) . The ELISA technique offers advantages over these other methods of measuring antibody to ACHO in that the assay is simple to perform and utilizes reagents that are easy to prepare and are stable for prolonged periods of time. In addition, the ELISA technique avoids the biohazards and expensive detection equipment required for the radioimmunoassay.
Previous observations on ACHO antibody levels in a variety of pathological conditions have given conflicting results. For example, Zimmerman et al. (25) , using a radial immunodiffusion technique, were not able to confirm the persistently high ACHO antibody levels in rheumatic fever patients reported by Dudding and Ayoub (7) . This was probably due to the fact that results with the different assay techniques are influenced by differences in antibody isotype, affinity, and possibly subclass (5, 22) . We have recently shown that there is poor correlation between ACHO antibody levels determined by radioimmunoassay and those determined by radial immunodiffusion (Ayoub, unpublished data). In contrast, results in this report show that antibody titers in the ELISA system, detected by polyvalent antibody to human immunoglobulins, correlate highly with the antigenbinding capacity by radioimmunoassay. Thus, the ELISA would be an excellent alternative assay to confirm these earlier findings.
The ELISA assay described here was designed to assess the total immunoglobulin or polyvalent antibody response to ACHO. Riesen et al. have suggested that human antibody to ACHO is restricted to the IgG isotype and the IgG2 subclass (18) . This finding can be confirmed by using a modification of our ELISA method. By altering the specificity of the alkaline-phosphatase conjugated anti-human immunoglobulin reagent, an isotype-specific or subclass-specific assay can be developed.
